Next Article in Journal
Distribution, Sources and Risk Assessment of Polychlorinated Biphenyls in Sediments from Beiluo River
Previous Article in Journal
Cytotoxicity and Oxidative Stress Effects of Indene on Coelomocytes of Earthworm (Eisenia foetida): Combined Analysis at Cellular and Molecular Levels
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Embryotoxicity and Teratogenicity of Steroidal Saponin Isolated from Ophiopholis mirabilis

1
Jiangsu Provincial Institute of Marine Resources Development, College of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China
2
Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences, Yantai 264003, China
3
College of Resources and Environment, University of Chinese Academy of Sciences, Beijing 100049, China
4
School of Ocean, Yantai University, Yantai 266071, China
5
School of Marine Science and Technology, Harbin Institute of Technology, Weihai 264209, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Toxics 2023, 11(2), 137; https://doi.org/10.3390/toxics11020137
Submission received: 9 January 2023 / Revised: 28 January 2023 / Accepted: 29 January 2023 / Published: 30 January 2023
(This article belongs to the Section Ecotoxicology)

Abstract

:
Benthic invertebrates produce secondary metabolites that serve as defenses against consumers and promote their fitness. To explore the chemical defense in marine benthic echinoderms, the chemical constituents of Ophiopholis mirabilis were investigated. A steroidal monoglycoside, asterosaponin P1, was isolated from O. mirabilis for the first-time using column chromatography. The chemical structure was characterized by spectroscopic and spectrometric methods. The embryotoxicity and teratogenicity of the isolated compound were assessed using the zebrafish embryo assay, a powerful vertebrate animal model system to study mechanisms of toxicity. When applied at high concentrations, asterosaponin P1 causes a significant increase in embryo mortality. A moderate LC50 of asterosaponin P1 appeared to be time- and concentration-dependent in its toxicity to zebrafish embryos. Teratogenicity in zebrafish embryos also included morphological defects, decreased hatchability, and a reduced heart rate. These findings revealed that steroidal saponin extracted from O. mirabilis exhibited acute toxic effects on zebrafish embryos, suggesting a potential chemical defense function in marine habitats.

Graphical Abstract

1. Introduction

The brittle star Ophiopholis mirabilis belongs to Echinodermata, Ophiuroidea, Gnathophiurina, Ophiactidae, Ophiopholis, is an important contributor to biomass in benthic ecosystems [1]. The Ophiuroidea, which account for nearly one-third of all species of extant echinoderms, are the largest group [2]. All seas have dense aggregations of brittle stars, which have evolved a variety of lifestyles and can be found from the intertidal zone to the deepest levels [3,4]. The majority of species live in crevices and holes in coral or rock, submerged in muck, or at the bottom of the ocean [2]. O. mirabilis is a widespread species that aggregates at the bottom of the Yellow Sea and is found along the western coasts of the northern Pacific Ocean [5,6]. O. mirabilis is an epizoic organism that inhabits numerous hosts such as sponges, cnidarians, ascidians, echinoderms, algae, bryozoans, and seahorses without camouflage in the southwest Atlantic [7]. Moreover, gorgonians and sponges are O. mirabilis’ primary hosts in the eastern Pacific [8]. Brittle stars distinguish themselves sharply from many host species in terms of color and visibility. They might therefore be born with an innate predator deterrent, such as chemical defenses. Their secondary metabolites, which have acute toxicity in the aquatic ecosystem, might be the potential chemical deterrent to effectively enhance their survival.
Previous chemical investigations of animals of the class Ophiuroidea have isolated several polyhydroxysteroid sulfates and saponins as the main classes of secondary metabolites [9,10,11,12,13]. Many of the steroid sulfates and crude extracts exhibited a broad spectrum of biological activity, including cytotoxicity [14], hemolytic activity [15], and repellant activity to other marine organisms [16]. Although the parameters for the extraction of saponin [17] and pepsin-soluble collagen [18] were optimized in O. mirabilis, there is no report on the secondary metabolites. Recent research has shown how saponin affects the hemolysis of red blood cells and can even be hazardous to some animal species [19,20]. To investigate toxicity mechanisms, zebrafish (Danio rerio) can be used as a robust vertebrate animal model system, which is a popular alternative to mammalian animal testing [21]. Due to its efficacy in both experimental and genetic analyses, zebrafish, as a model of conventional vertebrate development and disease pathogenesis, has attracted increased attention from the scientific community [22,23].
In this study, we investigated the putative chemical defense in O. mirabilis collected from the Changdao archipelago, the interface between the Yellow Sea and the Bohai Sea of China. The secondary metabolite was characterized, and its toxic effects on early vertebrate embryonic development were assessed using a zebrafish embryo assay. During the first four days of zebrafish growth, the effects of various steroidal monoglycoside sulfate concentrations were investigated with regard to mortality and morphological alterations. The research highlights the potential broad-spectrum chemical defenses of echinoderms by employing the zebrafish as a model animal and emphasizing the ecological role of secondary metabolites in marine ecosystems.

2. Materials and Methods

2.1. Sampling

The O. mirabilis (20.5 kg) was collected in Changdao Sea Area, Shandong, China (37°55′12″ N, 120°43′48″ E), in June 2020. The sample with the vibrant hue was chosen for further chemical investigation. A voucher specimen was deposited in our laboratory at −20 °C with reference number C2020-002.

2.2. Extraction and Isolation of Secondary Metabolites

The air-dried and ground O. mirabilis (20.5 kg) was extracted for 3 to 72 h at room temperature with 95% ethanol/water. After the solvent was removed under reduced pressure at <40 °C, a dark residue was obtained. The residue substance was suspended in water and then subsequently partitioned using petroleum ether, ethyl acetate, and n-butanol. According to the TLC analysis result, the n-butanol extract (172.3 g) was chromatographed over silica gel (1500 g), eluting with CH2Cl2–MeOH to give 15 fractions. Column chromatography (CC) was performed on silica gel (100–400 mesh, Qingdao Marine Chemical Factory). Fr. 10 (20.3 g) was further fractionated by common chromatography on silica gel eluting with a gradient of increasing MeOH (20–100%) in CH2Cl2 to yield two subfractions. A compound (4.5 mg) was produced by chromatographing the second sub-fraction twice over Sephadex LH-20 and eluting it with MeOH-H2O (1:1) and MeOH, respectively.

2.3. Chemical Structure Elucidation Procedures

On the AVANCE 500 MHz instrument (Bruker, Billerica, MA, USA), 1H and 13C/DEPT-NMR, two-dimensional homonuclear (i.e., COSY), and heteronuclear (i.e., HMQC and HMBC) analyses were carried out. Mass spectrometry was performed on a Waters ACQUITY H-Class UPLC system tandem a Waters Xevo TQ-S triple quadrupole time-of-flight mass spectrometer (Waters Corp., Milford, MA, USA).

2.4. Zebrafish Embryo Bioassay

The Yantai Institute of Coastal Zone Research, Chinese Academy of Sciences (2021R001) Animal Care Ethics Committee’s regulations were strictly followed when using animals in this study. Adult zebrafish breeding and embryo toxicity testing were carried out as instructed by Berry et al. [24,25]. Briefly, the zebrafish kept at 12/12 h light/dark conditions were placed in stainless mesh spawning cages in the morning with lights on (9:00–9:30 a.m.). Eggs that had been fertilized (4 h after fertilization, 4 hpf) were retrieved and then washed with egg water, a solution of sea salt with a conductivity of 500–550 s/cm. The preliminary experimental findings led to the maximal concentration of the chemical being established at 25.0 mg/L [26]. To examine the effects of the chemical on zebrafish at sub-lethal concentrations, 5.0, 7.5, 10.0, and 15.0 mg/L were tested. Using 12-well polypropylene plates, each treatment contained 4 wells with 12 embryos (48 embryos per treatment in 5 mL). Vehicle (DMSO-only) and “untreated” controls (egg water-only) were used in each assay; the solvent was removed from the assay plates before the medium and embryos were added, so no effects of the solvent were seen (compared to the untreated control). Up to 4 h post-ovulation, the embryos’ bioactivity was monitored. In addition to the percentage of hatching and mortality, the heartbeat of zebrafish embryos was recorded using photomicrography with an Olympus CKX53 digital camera for 20 s.

2.4.1. Dose-Response to Zebrafish Embryos

Zebrafish embryo mortality is used to gauge a species’ embryotoxic potential. Successfully fertilized embryos are chosen under a microscope for embryo exposure trials 3–4 h after zebrafish spawn. According to the research group’s preliminary experiments, the concentrations of asterosaponin P1 were 5, 7.5, 10, 15, and 25 mg/L, respectively. Ten fertilized eggs from each concentration were treated and transferred to 12-well plates. A 96-hour exposure experiment was then conducted, and 10 embryos per well were exposed to 5 mL of solution. Every 24 h, embryos are examined under a stereomicroscope to check for signs of embryonic death, which include coagulation and/or no heartbeat. Each experiment is conducted four times. Mortality is determined based on the number of dead embryos at each concentration of 96 hpf.

2.4.2. Zebrafish Embryo and Larvae Teratogenicity

After exposure to five different doses of asterosaponin P1, the teratogenicity of zebrafish was assessed by morphological changes and developmental abnormalities in both the embryos and the larvae. Every 24 h following treatment, the embryos and larvae were observed under a stereomicroscope. Pericardial edema, delayed yolk sac absorption, tail curvature, etc. are all regarded as abnormalities of embryonic development.

2.4.3. Zebrafish LC50 and Mortality Calculations

Take 96 hpf as an example of statistical methods of mortality over time: 96 hpf mortality rate (%) = (total number of accumulated dead embryos in 96 hpf/total number of embryos in the initial test) × 100%, and so on. The original data for each test level was then used to generate preliminary statistics. The exposure dose of half embryonal lethal (LC50) lysins at various exposure time periods was determined using Probit analysis and SPSS 10.0 statistical software.

2.4.4. Zebrafish Hatching Rate

Zebrafish embryos typically incubate for 48 to 96 hpf. According to the following statistical procedure, each period’s hatching rate is calculated. For instance, 96 hpf hatching rate (%) = (96 hpf hatching embryos total embryos) × 100%.

2.4.5. Zebrafish Deformity Rate

Every time period’s aberrant phenotypes were recorded, and the corresponding ratio was calculated. Pericardial edema, yolk sac edema, spinal curvature, and body length decrease are phenotypic abnormalities that may manifest in embryos.

2.5. Statistics

Four independent replications of each treatment were used in the investigations on embryotoxicity and teratogenicity. One-way analysis of variance (ANOVA) and Tukey’s multiple comparison test were used to compare the mortality of zebrafish embryos and teratogenicity test results. The mean ± standard deviation of the mean (SD) was used to present all data, and p < 0.05 was considered significant.

3. Results and Discussion

3.1. Chemical Structure Elucidation of Asterosaponin P1

The isolated compound (Figure 1) was obtained as a pale amorphous powder. The high-resolution negative ion mass spectral data gave a pseudomolecular ion of m/z 677.3580 [M − Na], corresponding to the molecular formula of C33H57NaO12S, (cal. 677.3571 [M − Na], Δ = 1.3 ppm).
1D- and 2D-NMR analysis was used to determine the compound. (Figures S2 and S3 and Table 1). Two methyl singlets representing the methyl groups C-18 and C-19 and three doublets for the methyl groups C-21, C-26, and C27 were detected in the 1H, 13C, and HSQC NMR spectra (Figures S2–S4). These methyl group indications pointed to a typical 27-carbon steroid skeleton, which was supported by the predicted chemical formula. Long-range communication between the methyl protons for Me-19 to a CH-5 (δC 53.7) was one of the crucial HMBC correlations. The COSY spectrum (Figure S5) showed correlations between CH-CH2-CH-CH-CH2 (Figure 2). The proton on C-14 also showed a COSY correlation to the CH at δH 4.21 (Figure 2), implying the oxygenation on C-15. The long-range communication between the methyl protons for Me-26 and Me-27 to carbinol methine proton at δC 84.7 allowed us to locate another site of oxygenation on C-24. These relationships were highly reminiscent of the hydroxylation pattern in asterosaponin P1 [27].
Accounting for the molecular formula deduced by HR-MS, we assume the composition of the C24 substituent to be a C6H10NaO8S subunit. A CH2 resonance at δH 4.12 was attached to a carbon having a chemical shift of δC 69.1 (HSQC). This is a characteristic set of chemical shifts for sulfated primary alcohol [28]. The COSY correlations of CH-CH-CH-CH-CH2 (Figure 2) constructed the monoglycoside moiety. In addition, the long-range correlations from H-1′ to C-2′ and C-3′, from H-5′ to C-3′ and C-4′, and from protons of oxygenated methyl to C-3′ confirmed the chemical structure of sugar moiety. Of note, the correlations between H-1′ to C-24 and H-24 to C-1′ in the HMBC spectrum confirmed the linkage of monosaccharide on C-24. Therefore, the planar structure was assigned as 5′-O-sulfate 24-(3-methyl-arabinofuranosyl)-3,6,8,15,24-pentaoxy-cholestane, consistent with asterosaponin P1 [27].
The NOESY (Figure 2) and coupling constant analysis supported the relative configuration in this case. The hydroxyls at C-3, C-6, and C-15 exhibited an equatorial orientation, according to the NOESY correlations detected from H-19 to H-6β, from H-15β to H-18, as well as on the counterpart, the correlations from H-3α to H-5α. Furthermore, in the NOESY spectrum (Figure 2), the correlations from H-1′ to H-3′, and from H-3′ to H-5′; on the counterpart, the H-2′ displayed a correlation with H-4′; the H-2′ also showed correlation with protons of oxygenated methyl, indicating the relative configurations on sugar subunit. Although the stereochemistry at C-24 is tentatively assigned as 24S by analogy with nodososide [29], the comparison of the chemical shifts presented an unambiguous answer to this question unless each of the C24-epimers has been synthesized. The chemical shifts of 1 show equal to the analogy of asterosaponin P1 and different from the desulfate analogy. Therefore, we concluded that the isolated compound is 5′-O-sulfate 24-(3-methyl-L-arabinofuranosyl)-3,6α,8,15α,24-pentaoxy-cholestane, asterosaponin P1.

3.2. Zebrafish Mortality and Hatching Rates Treated by Asterosaponin P1

Embryotoxicity was assessed at five different concentrations of asterosaponin P1 (5.0 mg/L, 7.5 mg/L, 10.0 mg/L, 20.0 mg/L, and 25.0 mg/L). The outcomes demonstrated that asterosaponin P1’s toxicity manifested in a concentration-dependent manner (Table S1). Figure 3A displayed the mean mortality of zebrafish at 96 hpf. The 0.1 DMSO (vehicle) caused no mortality in the zebrafish embryos. The lowest dose of asterosaponin P1 showed a significantly increased mortality rate (p < 0.05), although no viable mortality was observed in the groups treated with 7.5 mg/L of asterosaponin P1. The mortality rate of zebrafish embryos in the group treated with 10.0 mg/L, 15.0 mg/L, and 25.0 mg/L showed a significant increase. The sublethal endpoints (LC50) were 2.22 mg/L at 12 hpf, 23.33 mg/L at 24 hpf, 17.91 mg/L at 48 hpf, 14.58 mg/L at 72 hpf, and 13.35 mg/L at 96 hpf, respectively. Notably, higher doses of asterosaponin P1 were found to increase in embryotoxicity over the course of treatment (Table 2), suggesting that the toxicity of asterosaponin P1 appears to be concentration- and time-dependent manner in zebrafish embryos.
The hatching rate of zebrafish embryos treated with five different concentrations of asterosaponin P1 and 0.1% DMSO (vehicle) were presented in Figure 3B. All of the zebrafish embryos treated with control and vehicle were hatched successfully. As the treated concentration increased to 10.0 mg/L, the hatching rate of embryos showed a significantly decreased tendency. No hatching of any zebrafish embryos was observed in the 25.0 mg/L treated group.
The zebrafish heart rates at 48 hpf with different concentration treated were shown in Figure 3C. No significant difference between the means of the heart rates of the asterosaponin P1 (5.0 mg/L and 7.5 mg/L)-treated group and the 0.1% DMSO-treated group (vehicle). The average heart rate declined at the concentrations of 10.0 mg/L and above. The heartbeat decreased to 69.5 beats per minute (bpm) at 25.0 mg/L treated group, much lower than the normal heart rate of zebrafish embryos ranges from 120 to 180 bpm [30].

3.3. Teratogenicity of Zebrafish Embryos Treated by Asterosaponin P1

Saponins have some teratogenic effects on the growth and development of zebrafish embryos and juveniles [20]. No embryonic malformation was observed in the low concentration of asterosaponin P1 (≤5 mg/L). Zebrafish embryos were measured at various concentrations of asterosaponin P1 (5.0, 7.5, 10.0, 15.0, and 25.0 mg/L) across a range of exposure times (12–96 h) to analyze the saponin from O. mirabilis that caused teratogenicity. Table 2 displays the teratogenic consequences of asterosaponin P1 in zebrafish embryos. According to the findings, embryos exposed to astersaponin P1 at concentrations of 15.0 and 25.0 mg/L for 24 h had malformation rates of 10.76 ± 7.24% and 24.17 ± 9.36%, respectively. The results indicated that asterosaponin P1 was teratogenic to embryos at an early stage. Notably, at a concentration of 25.0 mg/L for 72 h, the greatest malformation rates were 90.25 ± 9.32%. The prolonged exposure period (96 h) at 25.0 mg/L resulted in no surviving embryo.
The morphology of the embryo was characterized by the presence of the unclosed blastopore (UB, Figure 4B), pericardial edema (PE, Figure 4D), and spinal curvature (SC, Figure 4F). Zebrafish embryos exposed to 25.0 mg/L at 12 h displayed an open blastopore (Figure 4B). The spinal abnormalities in the remaining embryos exposed to 15.0 mg/L ranged from 24.67 to 2.23% at 72 h and included caudal developmental problems (Figure 4F). A 100% mortality rate was observed after 96 h of exposure to 15.0 mg/L astersaponin P1. It’s interesting to note that neither the control group nor the 7.5 mg/L group of zebrafish embryos displayed any teratogenic abnormalities during the study (Figure 4A,C,E).

4. Conclusions

In our investigation of the chemical defenses in marine benthic echinoderms, asterosaponin P1 was isolated from brittle star O. mirabilis for the first time. Although brittle star merely contained a minute amount of asterosaponin P1, experiments on zebrafish embryos showed that it was teratogenic and embryotoxic, suggesting that it may have chemical defenses against nearby swimming predators. The toxicity of crude plant extracts containing saponins has been evaluated using the zebrafish embryos model [31,32,33], our study firstly provided the evidence that steroidal saponin isolated from marine invertebrates has a high impact on the growth and development of zebrafish embryos and had teratogenic effects on the morphology of zebrafish. Our findings highlight the chemoecological functions of steroidal saponins of echinoderms origin, providing insight into the chemical defenses of marine benthic echinoderms.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/toxics11020137/s1, Figure S1: HR-ESI-MS of asterosaponin P1; Figure S2: 1H NMR spectrum of asterosaponin P1; Figure S3: 13C NMR and DEPT spectra of asterosaponin P1; Figure S4: 1H-1H COSY spectrum of asterosaponin P1; Figure S5: HSQC spectrum of asterosaponin P1; Figure S6: HMBC spectrum of asterosaponin P1; Figure S7: NOESY spectrum of asterosaponin P1; Table S1: Results of acute toxicity experiments of asterosaponin P1 on zebrafish embryos.

Author Contributions

Q.X. and K.L. designed the study. K.L. obtained funding. Q.X., R.Z. and Z.Y. performed the compound purification and identification, X.Y. and A.L. performed the toxicity experiments, X.Y. and Y.L. (Yaxi Li) conducted the data analysis. X.L., B.M. and Y.L. (Yanfang Liu) harvested the specimen. K.L., X.Y. and Q.X. wrote the manuscript. S.H. and L.C. provided suggestions. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Science Foundation of China (32270533). The corresponding author K.L. appreciates the Taishan Scholar Program from Shandong Province of China (tsqn20190403), the National Overseas High-level Talent Program, and the Shuangbai Plan from Yantai Municipal City (2018020) for their support.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Animal Care and Use Committee of Yantai Institute of Coastal Zone Research, CAS (Protocol #001/2021 and approval by April 2021).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Acknowledgments

We are grateful to Quanchao Wang for helping us identify the brittle stars.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Liao, Y. Fauna Sinica, Invertebrata Vol. 40: Echinodermata, Ophiuroidea; ConchBooks: Harxheim, Germany, 2004. [Google Scholar]
  2. Stöhr, S.; O’Hara, T.D.; Thuy, B. Global diversity of brittle stars (Echinodermata: Ophiuroidea). PLoS ONE 2012, 7, e31940. [Google Scholar] [CrossRef] [PubMed]
  3. Broom, D. Aggregation behaviour of the brittle-star Ophiothrix fragilis. J. Mar. Biol. Assoc. UK 1975, 55, 191–197. [Google Scholar] [CrossRef]
  4. Thuy, B. Exceptionally well-preserved brittle stars from the Pliensbachian (Early Jurassic) of the French Ardennes. Palaeontology 2011, 54, 215–233. [Google Scholar] [CrossRef]
  5. Yu, N.; Sun, S.; Zhang, G.; Zhang, F. Reproductive cycle of Ophiopholis mirabilis (Echinodermata: Ophiuroidea) in Zhangzi Island area, northern Yellow Sea. J. Oceanol. Limnol. 2021, 39, 173–184. [Google Scholar] [CrossRef]
  6. Yu, N.; Sun, S.; Wang, S.; Liu, Q.; Zhang, G.; Zhang, F.; Sun, X. An enhanced underwater camera apparatus for seabed observation of megabenthic epifauna in the northern Yellow Sea. J. Oceanol. Limnol. 2020, 38, 1799–1810. [Google Scholar] [CrossRef]
  7. Mantelatto, M.C.; Vidon, L.F.; Silveira, R.B.; Menegola, C.; Rocha, R.M.d.; Creed, J.C. Host species of the non-indigenous brittle star Ophiothela mirabilis (Echinodermata: Ophiuroidea): An invasive generalist in Brazil? Mar. Biodivers. Rec. 2016, 9, 1–7. [Google Scholar] [CrossRef] [Green Version]
  8. Alvarado, J.J.; Fernández, C. Equinodermos del Parque Nacional Marino Ballena, Pacífico, Costa Rica. Rev. De Biol. Trop. 2005, 53, 275–284. [Google Scholar]
  9. Dauria, M.V.; Riccio, R.; Minale, L.; Labarre, S.; Pusset, J. Novel marine steroid sulfates from Pacific ophiuroids. J. Org. Chem. 1987, 52, 3947–3952. [Google Scholar] [CrossRef]
  10. Fedorov, S.N.; Levina, E.V.; Kalinovsky, A.I.; Dmitrenok, P.S.; Stonik, V.A. Sulfated steroids from pacific brittle stars Ophiopholis aculeata, Ophiura sarsi, and Stegophiura brachiactis. J. Nat. Prod.-Lloydia 1994, 57, 1631–1637. [Google Scholar] [CrossRef]
  11. Dauria, M.V.; Paloma, L.G.; Minale, L.; Riccio, R.; Zampella, A. On the composition of sulfated polyhydroxysteroids in some ophiuroids and the structure determination of six new constituents. J. Nat. Prod. 1995, 58, 189–196. [Google Scholar] [CrossRef]
  12. Roccatagliata, A.J.; Maier, M.S.; Seldes, A.M.; Pujol, C.A.; Damonte, E.B. Antiviral sulfated steroids from the ophiuroid Ophioplocus januarii. J. Nat. Prod. 1996, 59, 887–889. [Google Scholar] [CrossRef] [PubMed]
  13. Roccatagliata, A.J.; Maier, M.S.; Seldes, A.M. New sulfated polyhydroxysteroids from the Antarctic ophiuroid Astrotoma agassizii. J. Nat. Prod. 1998, 61, 370–374. [Google Scholar] [CrossRef] [PubMed]
  14. Klimenko, A.; Huber, R.; Marcourt, L.; Chardonnens, E.; Koval, A.; Khotimchenko, Y.S.; Ferreira Queiroz, E.; Wolfender, J.-L.; Katanaev, V.L. A Cytotoxic Porphyrin from North Pacific Brittle Star Ophiura sarsii. Mar. Drugs 2021, 19, 11. [Google Scholar] [CrossRef] [PubMed]
  15. Ivanchina, N.V.; Kicha, A.A.; Kalinovsky, A.I.; Dmitrenok, P.S.; Stonik, V.A. Hemolytic steroid disulfates from the far eastern starfish Pteraster pulvillus. J. Nat. Prod. 2003, 66, 298–301. [Google Scholar] [CrossRef] [PubMed]
  16. Iken, K.; Greer, S.P.; Amsler, C.D.; McClintock, J.B. A new antifouling bioassay monitoring brown algal spore swimming behaviour in the presence of echinoderm extracts. Biofouling 2003, 19, 327–334. [Google Scholar] [CrossRef]
  17. Wang, R.; Dang, Y.; Feng, J.; Wang, Q.; Dai, P.; Guo, C. Optimization of the extraction of ophiurasaponin from Ophiopholis mirabilis with the orthogonal design method. Mar. Sci. 2012, 36, 46–49. [Google Scholar]
  18. Jiang, B.; Wang, Q.; He, Y.; Ren, D. Extraction of collagen from brittle star Ophiopholis mirabilis. J. Dalian Ocean Univ. 2013, 28, 498–501. [Google Scholar]
  19. Hassan, S.M.; Moussa, E.A.; Abbott, L.C. Effects of quillaja saponin (Quillaja saponaria) on early embryonic zebrafish (Danio rerio) development. Int. J. Toxicol. 2008, 27, 273–278. [Google Scholar] [CrossRef]
  20. Jiang, X.; Cao, Y.; Jorgensen, L.v.G.; Strobel, B.W.; Hansen, H.C.B.; Cedergreen, N. Where does the toxicity come from in saponin extract? Chemosphere 2018, 204, 243–250. [Google Scholar] [CrossRef] [PubMed]
  21. Modarresi Chahardehi, A.; Arsad, H.; Lim, V. Zebrafish as a Successful Animal Model for Screening Toxicity of Medicinal Plants. Plants 2020, 9, 1345. [Google Scholar] [CrossRef]
  22. Howe, K.; Clark, M.D.; Torroja, C.F.; Torrance, J.; Berthelot, C.; Muffato, M.; Collins, J.E.; Humphray, S.; McLaren, K.; Matthews, L. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013, 496, 498–503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Gomes, M.C.; Mostowy, S. The Case for Modeling Human Infection in Zebrafish. Trends Microbiol. 2020, 28, 10–18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Berry, J.P.; Gantar, M.; Gibbs, P.D.L.; Schmale, M.C. The zebrafish (Danio rerio) embryo as a model system for identification and characterization of developmental toxins from marine and freshwater microalgae. Comp. Biochem. Physiol. C-Toxicol. Pharmacol. 2007, 145, 61–72. [Google Scholar] [CrossRef] [Green Version]
  25. Berry, J.P.; Gibbs, P.D.L.; Schmale, M.C.; Saker, M.L. Toxicity of cylindrospermopsin, and other apparent metabolites from Cylindrospermopsis raciborskii and Aphanizomenon ovalisporum, to the zebrafish (Danio rerio) embryo. Toxicon 2009, 53, 289–299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Fikirdesici, S.; Altindag, A.; Ozdemir, E. Investigation of acute toxicity of cadmium-arsenic mixtures to Daphnia magna with toxic units approach. Turk. J. Zool. 2012, 36, 543–550. [Google Scholar] [CrossRef]
  27. Kicha, A.A.; Kalinovsky, A.I.; Levina, E.V.; Stonik, V.A.; Elyakov, G.B. Asterosaponin-P1 from the starfish Patiria pectinifera. Tetrahedron Lett. 1983, 24, 3893–3896. [Google Scholar] [CrossRef]
  28. Iorizzi, M.; Bryan, P.; McClintock, J.; Minale, L.; Palagiano, E.; Maurelli, S.; Riccio, R.; Zollo, F. Chemical and biological investigation of the polar constituents of the starfish Luidia clathrata, collected in the gulf of mexico. J. Nat. Prod. 1995, 58, 653–671. [Google Scholar] [CrossRef] [PubMed]
  29. Decorrea, R.S.; Riccio, R.; Minale, L.; Duque, C. Starfish saponins, Part 21. steroidal glycosides from the starfish Oreaster reticulatus. J. Nat. Prod. 1985, 48, 751–755. [Google Scholar] [CrossRef]
  30. De Luca, E.; Zaccaria, G.M.; Hadhoud, M.; Rizzo, G.; Ponzini, R.; Morbiducci, U.; Santoro, M.M. ZebraBeat: A flexible platform for the analysis of the cardiac rate in zebrafish embryos. Sci. Rep. 2014, 4, 1–13. [Google Scholar] [CrossRef] [Green Version]
  31. Hayati, F.; Chabib, L.; Fauzi, I.S.; Awaluddin, R.; Sumayya; Faizah, W.S.; Mohd Nasir, M.H.; Nipun, T.S. Effects of Pegagan (Centella asiatica L.) Ethanolic Extract SNEDDS (Self-nanoemulsifying Drug Delivery Systems) on the Development of Zebrafish (Danio rerio) Embryos. J. Pharm. Bioallied Sci. 2020, 12, 457–461. [Google Scholar] [CrossRef] [PubMed]
  32. Mohamad Shariff, N.F.S.; Singgampalam, T.; Ng, C.H.; Kue, C.S. Antioxidant activity and zebrafish teratogenicity of hydroalcoholic Moringa oleifera L. leaf extracts. Br. Food J. 2020, 122, 3129–3137. [Google Scholar] [CrossRef]
  33. Du, Z.-C.; Xia, Z.-S.; Huang, Y.-F.; Peng, Y.; Cao, B.-B.; Li, C.-Q.; Liang, Y.-F.; Zhao, F.-H.; Zhang, M.-Z.; Chen, Z.-M.; et al. Cardiotoxicity induced by Cochinchina momordica seed extract in zebrafish. J. Appl. Toxicol. 2021, 41, 1222–1231. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structure of asterosaponin P1.
Figure 1. Chemical structure of asterosaponin P1.
Toxics 11 00137 g001
Figure 2. Key correlation of COSY, HMBC, and NOESY of asterosaponin P1.
Figure 2. Key correlation of COSY, HMBC, and NOESY of asterosaponin P1.
Toxics 11 00137 g002
Figure 3. Cumulative mortality (A) and hatching efficiency (B) of zebrafish embryos exposed to asterosaponin P1 at 96 hpf, and heart rate (bpm) at 48 hpf (C), with a series of dilution concentrations of 5.0, 7.5, 10.0, 15.0, 25.0 mg/L, and 0.1% DMSO (vehicle). Zebrafish embryos’ coagulation and absence of a heartbeat were signs of mortality. Based on embryo deaths following exposure, percentages of embryonic mortality were estimated. Data represent the mean ± SD of four independent experiments (n = 12 embryos/group). Tukey’s multiple comparison test and one-way ANOVA were used to examine the results of the experiments. Significant differences across groups are denoted by different lowercase letters (p < 0.05).
Figure 3. Cumulative mortality (A) and hatching efficiency (B) of zebrafish embryos exposed to asterosaponin P1 at 96 hpf, and heart rate (bpm) at 48 hpf (C), with a series of dilution concentrations of 5.0, 7.5, 10.0, 15.0, 25.0 mg/L, and 0.1% DMSO (vehicle). Zebrafish embryos’ coagulation and absence of a heartbeat were signs of mortality. Based on embryo deaths following exposure, percentages of embryonic mortality were estimated. Data represent the mean ± SD of four independent experiments (n = 12 embryos/group). Tukey’s multiple comparison test and one-way ANOVA were used to examine the results of the experiments. Significant differences across groups are denoted by different lowercase letters (p < 0.05).
Toxics 11 00137 g003
Figure 4. Effect of asterosaponin P1 from O. mirabilis on typical malformations in zebrafish embryos. The zebrafish embryos were exposed to 0.1% DMSO (vehicle), and 5.0, 7.5, 10.0, 15.0 and 25.0 mg/L of asterosaponin P1. The normal morphology of zebrafish embryo and larvae exposure to filtered water and to 0.1% DMSO (vehicle) at 12 h (A), 48 h (C) and 72 h (E). Typical malformations caused by 15.0 mg/L of asterosaponin P1 on zebrafish embryonic development at 12 h (B), 48 h (D) and 72 h (F). Description: embryo with teratogenic effect (B,D,F). Abbreviations: TD, tail extension deformity; SC, spinal column curving; PE, pericardial edema, and UB, unclosed blastopore. (Scale bars = 2 μm).
Figure 4. Effect of asterosaponin P1 from O. mirabilis on typical malformations in zebrafish embryos. The zebrafish embryos were exposed to 0.1% DMSO (vehicle), and 5.0, 7.5, 10.0, 15.0 and 25.0 mg/L of asterosaponin P1. The normal morphology of zebrafish embryo and larvae exposure to filtered water and to 0.1% DMSO (vehicle) at 12 h (A), 48 h (C) and 72 h (E). Typical malformations caused by 15.0 mg/L of asterosaponin P1 on zebrafish embryonic development at 12 h (B), 48 h (D) and 72 h (F). Description: embryo with teratogenic effect (B,D,F). Abbreviations: TD, tail extension deformity; SC, spinal column curving; PE, pericardial edema, and UB, unclosed blastopore. (Scale bars = 2 μm).
Toxics 11 00137 g004
Table 1. 1H, 13C NMR data of asterosaponin P1 (MeOH, δ/ppm).
Table 1. 1H, 13C NMR data of asterosaponin P1 (MeOH, δ/ppm).
No.δH (J in Hz)δCNo.δH (J in Hz)δC
1a 1.73 (m)39.7 (CH2)16a 1.90 (m)42.0 (CH2)
1b0.98 (m) 16b1.78 (m)
2a 1.73 (m)31.6 (CH2)17 1.35 (m)56.2 (CH)
2b1.47 (m) 18 0.97 (s)15.6 (CH3)
3 3.48 (m)72.3 (CH)19 1.02 (s)14.4 (CH3)
4a 2.19 (m)32.5 (CH2)20 1.33 (m)36.5 (CH)
4b1.20 (m) 21 0.90 (d, 6.5)19.1 (CH3)
5 1.03 (m)53.7 (CH)22a 1.64 (m)33.3 (CH2)
6 3.61 (m) 67.8 (CH)22b0.92 (m)
7a 2.39 (dd, 13.5, 4.0)50.4 (CH2)23a1.56 (m)28.9 (CH2)
7b1.37 (m) 23b1.23 (m)
8 --76.2 (qC)243.29 (m)84.7 (CH)
9 0.87 (m)57.4 (CH)251.84 (m)32.0 (CH)
10 --38.0 (qC)260.90 (d, 6.5)18.3 (CH3)
11a 1.69 (m)19.8 (CH2)270.90 (d, 6.5)18.7 (CH3)
11b1.50 (m) 1′4.94 (s)109.7 (CH)
12a 1.95 (m)43.0 (CH2)2′4.04 (m)81.8 (CH)
12b1.25 (m) 3′3.59 (dd, 5.7, 2.4)89.5 (CH)
13 --45.6 (qC)4′4.19 (m)82.0 (CH)
14 1.29 (m)67.1 (CH)5′4.12 (d, 5.1)69.1 (CH2)
15 4.21 (m)69.9 (CH)OMe3.44 (s)58.6 (CH3)
Table 2. Teratogenic effects of asterosaponin P1 from O. mirabilis on early development of zebrafish. The zebrafish embryos were treated to 0.1% DMSO (control), and 5.0, 7.5, 10.0, 15.0 and 25.0 mg/L of the asterosaponin P1 at different times of exposure (12, 24, 48, 72 and 96 h). Descriptive data represent the mean ± SD of teratogenic embryo percentage of four independent experiments (n = 40 per group). NE = no surviving embryo.
Table 2. Teratogenic effects of asterosaponin P1 from O. mirabilis on early development of zebrafish. The zebrafish embryos were treated to 0.1% DMSO (control), and 5.0, 7.5, 10.0, 15.0 and 25.0 mg/L of the asterosaponin P1 at different times of exposure (12, 24, 48, 72 and 96 h). Descriptive data represent the mean ± SD of teratogenic embryo percentage of four independent experiments (n = 40 per group). NE = no surviving embryo.
Concentrations (mg/L)Times of Exposure (h)
1224487296
000000
5.0 00000
7.5 00000
10.0 0024.67 ± 2.2358.1 ± 8.5782.30 ± 8.10
15.0 010.76 ± 7.2439.26 ± 7.1575.36 ± 3.94NE
25.0 024.17 ± 9.3649.23 ± 9.7590.25 ± 9.32NE
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Xu, Q.; Yang, X.; Zhang, R.; Li, Y.; Yan, Z.; Li, X.; Ma, B.; Liu, Y.; Lin, A.; Han, S.; et al. Embryotoxicity and Teratogenicity of Steroidal Saponin Isolated from Ophiopholis mirabilis. Toxics 2023, 11, 137. https://doi.org/10.3390/toxics11020137

AMA Style

Xu Q, Yang X, Zhang R, Li Y, Yan Z, Li X, Ma B, Liu Y, Lin A, Han S, et al. Embryotoxicity and Teratogenicity of Steroidal Saponin Isolated from Ophiopholis mirabilis. Toxics. 2023; 11(2):137. https://doi.org/10.3390/toxics11020137

Chicago/Turabian Style

Xu, Qian, Xiao Yang, Ranran Zhang, Yaxi Li, Zhi Yan, Xiaodong Li, Bing Ma, Yanfang Liu, Ainuo Lin, Shaoshuai Han, and et al. 2023. "Embryotoxicity and Teratogenicity of Steroidal Saponin Isolated from Ophiopholis mirabilis" Toxics 11, no. 2: 137. https://doi.org/10.3390/toxics11020137

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop